Rosiglitazone suppresses glioma cell growth and cell cycle by blocking the transforming growth factor-beta mediated pathway.
about
The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cells.CCAAT enhancer binding protein β has a crucial role in regulating breast cancer cell growth via activating the TGF-β-Smad3 signaling pathway.
P2860
Rosiglitazone suppresses glioma cell growth and cell cycle by blocking the transforming growth factor-beta mediated pathway.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Rosiglitazone suppresses gliom ...... factor-beta mediated pathway.
@en
Rosiglitazone suppresses gliom ...... factor-beta mediated pathway.
@nl
type
label
Rosiglitazone suppresses gliom ...... factor-beta mediated pathway.
@en
Rosiglitazone suppresses gliom ...... factor-beta mediated pathway.
@nl
prefLabel
Rosiglitazone suppresses gliom ...... factor-beta mediated pathway.
@en
Rosiglitazone suppresses gliom ...... factor-beta mediated pathway.
@nl
P2093
P2860
P1476
Rosiglitazone suppresses gliom ...... factor-beta mediated pathway.
@en
P2093
P2860
P2888
P304
P356
10.1007/S11064-012-0828-8
P577
2012-06-16T00:00:00Z